Commissioning

In December 2022, NHS England published an update of the Specialized Services Policy Pipeline (as of December 6, 2022). No new MedTech-related Clinical Commissioning Policies were added to the work program, and three new policies were published in the period from September 6, 2022, to December 6, 2022. The status of ongoing policies was updated as well.

On November 25, 2022, the Treatment Council (Behandlingsråd) announced the third topic selected for major analyses (større analyser) for 2023. The selected topic is regarding the non-invasive treatment of obstructive sleep apnea.

On October 11, 2022, the Treatment Council (Behandlingsråd) announced the selection of two topics for major analyses (større analyser) for 2023, including the use of home non-invasive ventilation and the use of internet-based cognitive behavioral therapy.

NHS England is currently developing a Service Specification for NHS Clinical Genomic Services (NHS CGSs). On September 01, 2022, draft Service Specification and supporting documents were published for consultation. The deadline for comments submission is September 30, 2022.

On September 01, 2022, NHS England published an update of the Specialized Services Policy Pipeline (as of August 24, 2022). Two new MedTech-related Clinical Commissioning Policies were added to the work program (transcatheter edge-to-edge repair of the mitral valve, pectus surgery for really severe pectus), and no new policies were published. The status of ongoing policies was updated as well.

NHS England and NHS Improvement (NHSEI) have been changing the organizational landscape of the healthcare system for several years by developing new geographically-based partnerships called Integrated Care Systems (ICSs), bringing together providers and commissioners of NHS services with local authorities and other local partners to plan, coordinate and commission health and care services. On July 01, 2022, 42 ICSs became fully operational on a statutory basis of the 2022 Health and Care Act. Clinical Commissioning Groups (CCGs) are now abolished and replaced by 42 Integrated Care Boards (ICBs)

On February 14, 2022, the Danish Treatment Council (Behandlingsråd), a new body for assessing treatments and health technologies that became fully operational in late May 2021, has announced its symposium, which will take place in Aalborg on May 11, 2022.

On December 9, 2021, the Danish Treatment Council (Behandlingsråd), during its meeting, approved three topics selected for developing the so-called major analyses (større analyser) in 2022. The approved topics include handheld focused ultrasound in emergency medicine, artificial intelligence (AI) as decision support for colonoscopy, and intelligent/high-tech beds for use in intensive care units.

In late October 2021, the Treatment Council (Behandlingsråd) published three topics chosen for developing the so-called major analyses (større analyser) in 2022. The selected topics include patient-centered diabetes technology, hand-held focused ultrasound in emergency medicine, and artificial intelligence as decision support for colonoscopy.

On October 7, 2021, the Treatment Council (Behandlingsråd), a new body for assessing treatments and health technologies that became fully operational in late May 2021, has decided to initiate its first assessment. It will concern the use of metal stents in the treatment of chronic ureteral strictures.

On August 05, 2021, NHS England published an update of the Specialized Services Policy Pipeline (covering April 27, 2021 - July 27, 2021). No new MedTech-related Clinical Commissioning Policies were added to the work program. Nine new policies were published; however, only two concerned MedTech (ECMO and brachytherapy). The status of ongoing policies was updated as well.

On July 01, 2021, NHS England published an update of the Specialized Services Policy Pipeline (covering March 21, 2021 - June 21, 2021). One new Clinical Commissioning Policy related to radiotherapy was published. Three new policies were added to the work program; however, all related to pharmaceuticals only. The status of ongoing policies was updated as well.